(Q45921170)

17 December 2017

title

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat. (English)

1 reference

17 December 2017

author

Jo C. Neill

4

1 reference

17 December 2017

Samantha L McLean

0 references

author name string

Samantha L McLean

1

1 reference

17 December 2017

Marie L Woolley

2

1 reference

17 December 2017

Dave Thomas

3

1 reference

17 December 2017

publication date

21 July 2009

1 reference

17 December 2017

published in

Psychopharmacology

1 reference

17 December 2017

volume

206

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

403-414

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s00213-009-1618-0

exact match

0 references

cites work

Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1618-0

Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1618-0

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1618-0

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1618-0

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1618-0

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-009-1618-0

Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.

21 January 2018

1 reference

12 December 2020

RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist

1 reference

12 December 2020

Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites

1 reference

12 December 2020

SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

1 reference

12 December 2020

What the CATIE study means for clinical practice

1 reference

12 December 2020

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

1 reference

12 December 2020

Difficulty overcoming learned non-reward during reversal learning in rats with ibotenic acid lesions of orbital prefrontal cortex.

1 reference

12 December 2020

The potential utility of 5-HT1A receptor antagonists in the treatment of cognitive dysfunction associated with Alzheimer s disease

1 reference

12 December 2020

Effects of the 5-HT(7) receptor antagonist SB-258741 in animal models for schizophrenia

1 reference

12 December 2020

[3H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues

1 reference

12 December 2020

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

1 reference

12 December 2020

Molecular targets for treating cognitive dysfunction in schizophrenia.

1 reference

12 December 2020

Functional, molecular and pharmacological advances in 5-HT7 receptor research

1 reference

12 December 2020

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

1 reference

12 December 2020

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

1 reference

12 December 2020

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

1 reference

12 December 2020

Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia

1 reference

12 December 2020

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

1 reference

12 December 2020

Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats

1 reference

12 December 2020

Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells

1 reference

12 December 2020

Effects of the 5-HT7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task

1 reference

12 December 2020

Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia

1 reference

12 December 2020

On the nature of Wisconsin Card Sorting Test performance in schizophrenia

1 reference

12 December 2020

Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors

1 reference

12 December 2020

Dissociable effects of selective 5-HT2A and 5-HT2C receptor antagonists on serial spatial reversal learning in rats

1 reference

12 December 2020

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia

1 reference

12 December 2020

Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins

1 reference

12 December 2020

A deficit profile of executive, memory, and motor functions in schizophrenia.

1 reference

12 December 2020

Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist

1 reference

12 December 2020

Role of serotonin in the action of atypical antipsychotic drugs

1 reference

12 December 2020

Cognitive impairment in schizophrenia is the core of the disorder.

1 reference

12 December 2020

5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.

1 reference

12 December 2020

Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia.

1 reference

12 December 2020

A review of central 5-HT receptors and their function

1 reference

12 December 2020

GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder

1 reference

12 December 2020

The effect of chronic clozapine and haloperidol on basal dopamine release and metabolism in rat striatum and nucleus accumbens studied by in vivo microdialysis

1 reference

12 December 2020

D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.

1 reference

12 December 2020

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors

1 reference

12 December 2020

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

12 December 2020

Influence of gender on working and spatial memory in the novel object recognition task in the rat.

1 reference

12 December 2020

Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia.

1 reference

12 December 2020

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

1 reference

12 December 2020

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

1 reference

12 December 2020

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

1 reference

12 December 2020

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity

1 reference

12 December 2020

A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia

1 reference

12 December 2020

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

1 reference

12 December 2020

Premorbid intellectual functioning and risk of schizophrenia and spectrum disorders.

1 reference

12 December 2020

Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats--a preliminary investigation

1 reference

12 December 2020

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

12 December 2020

Opposing effects of AMPA and 5-HT1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus.

1 reference

12 December 2020

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

1 reference

12 December 2020

Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970.

1 reference

12 December 2020

1 reference

12 December 2020

Effect of SB-243213, a selective 5-HT(2C) receptor antagonist, on the rat sleep profile: a comparison to paroxetine

1 reference

12 December 2020

Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition

1 reference

12 December 2020

Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its a

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

1 reference

12 December 2020

WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801.

1 reference

12 December 2020

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

1 reference

12 December 2020

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage

1 reference

12 December 2020

1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat.

1 reference

12 December 2020

Role of 5-HT(2C) receptors in the control of central dopamine function

1 reference

12 December 2020

The primacy of cognition in schizophrenia

1 reference

12 December 2020

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors

1 reference

12 December 2020

Schizophrenia and cognitive function

1 reference

12 December 2020

Effects of orbitofrontal, infralimbic and prelimbic cortical lesions on serial spatial reversal learning in the rat.

1 reference

12 December 2020

Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat.

1 reference

12 December 2020

Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera.

1 reference

12 December 2020

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

12 December 2020

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

1 reference

12 December 2020

Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors

1 reference

12 December 2020

Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study

1 reference

12 December 2020

Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.

1 reference

12 December 2020

Interactions between neuroleptics and 5-HT(1A) ligands in preclinical behavioral models for antipsychotic and extrapyramidal effects

1 reference

12 December 2020

10.1007/S00213-009-1618-0

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1017322145

0 references

1 reference

17 December 2017